drugset / Trial / NCT05284656

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

NCT05284656

Phase 3 Active not recruiting 80 enrolled Al-Azhar University
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to evaluate the effect of administration of folic acid and /or pentoxifylline on patients with chronic kidney disease (CKD).

Timeline

Start
2022-01-08
Primary completion
2026-06-12
Completion
2026-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 400 mg
Subject folic acid Other / unclassified 500 ug
Subject folic acid Other / unclassified 5 mg